Literature DB >> 7666304

Nonoperative initial management versus silon chimney for treatment of giant omphalocele.

J G Nuchtern1, R Baxter, E I Hatch.   

Abstract

Giant omphalocele is a major clinical challenge for pediatric surgeons. Whereas small- to medium-sized defects can be repaired primarily, larger omphaloceles cannot be closed at birth because the liver and small bowel have lost the right of domain to the abdomen. Two divergent strategies have evolved for treating these giant defects: (1) use of a silon chimney with gradual reduction of the contents of the sac, and (2) initial nonoperative management (epithelialization) of the omphalocele followed by repair of the residual ventral hernia. In an 18-year retrospective study, we have reviewed our experience with these treatment methods. Ninety-four infants underwent treatment for omphalocele between 1975 and 1993. Primary closure (PC) was possible in 55 patients, silon chimney (SC) was used in 15, and 7 had nonoperative management (NM) with epithelialization. In the remaining 17 infants, surgery was believed to be inappropriate because of the lethality of their associated anomalies. Major (but potentially survivable) anomalies were present in 26% of PC, 13% of SC, and 71% of the NM group patients. The majority of the liver was present in 73% of SC- and 86% of NM-treated omphaloceles. There was a decrease in length of stay, time to enteral feeding, and mortality over the 18-year period. However, those patients whose defects could not be closed primarily had consistently longer hospital stays. This was particularly true for the SC patients. The decreased use of total parenteral nutrition seems to reflect a shift from SC to NM rather than a decrease in the interval to full enteral feeding in any given treatment group over time.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666304     DOI: 10.1016/0022-3468(95)90745-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Successful sequential sac ligation for an unruptured giant omphalocele: report of a case.

Authors:  Tsuyoshi Shinohara; Mineyuki Tsuda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Successful vaginal delivery following laparoscopic abdominal wall reconstruction in an adult survivor of an omphalocele without prior surgical repair: report of a case.

Authors:  W B Kim; J Kim; Y J Boo; S H Park; T J Song; S O Suh
Journal:  Hernia       Date:  2008-12-16       Impact factor: 4.739

3.  Non-operative management of giant omphalocele with topical povidone-iodine and powdered antibiotic combination: early experience from a tertiary centre.

Authors:  Vaibhav Pandey; A N Gangopadhyay; D K Gupta; S P Sharma; Vijayendar Kumar
Journal:  Pediatr Surg Int       Date:  2014-02-09       Impact factor: 1.827

4.  Closure of the ventral hernia in the management of giant exomphalos: a word of caution.

Authors:  M Kothari; Percy W B Pease
Journal:  Pediatr Surg Int       Date:  2005-01-13       Impact factor: 1.827

5.  Has the liver and other visceral organs migrated to its normal position in children with giant omphalocele? A follow-up study with ultrasonography.

Authors:  Floortje Clemens van Eijck; Willemijn M Klein; Carla Boetes; Daniel C Aronson; Rene M H Wijnen
Journal:  Eur J Pediatr       Date:  2009-09-29       Impact factor: 3.183

6.  Exomphalos major: the Northern Ireland experience.

Authors:  P Charlesworth; E Ervine; M McCullagh
Journal:  Pediatr Surg Int       Date:  2008-11-12       Impact factor: 1.827

Review 7.  Fetal counselling for congenital malformations.

Authors:  Kokila Lakhoo
Journal:  Pediatr Surg Int       Date:  2007-03-14       Impact factor: 2.003

8.  Initial conservative management of exomphalos major with gentian violet.

Authors:  Ashrarur Rahman Mitul; Kmn Ferdous
Journal:  J Neonatal Surg       Date:  2012-10-01

9.  Topical treatment of major omphalocoele: Acacia nilotica versus povidone-iodine: A randomised controlled study.

Authors:  Almoutaz A Eltayeb; Mahmoud M Mostafa
Journal:  Afr J Paediatr Surg       Date:  2015 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.